US 11780907
Human antibodies to influenza hemagglutinin
granted A61KA61K2039/505A61K31/215
Quick answer
US patent 11780907 (Human antibodies to influenza hemagglutinin) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K31/215, A61K39/42, A61P